Mattsson A, Rudén B I, Hall P, Wilking N, Rutqvist L E
Oncologic Center, Karolinska Hospital, Stockholm, Sweden.
J Natl Cancer Inst. 1993 Oct 20;85(20):1679-85. doi: 10.1093/jnci/85.20.1679.
From the 1920s through the 1950s, radiation therapy was used in Sweden as a treatment for benign breast diseases. It is now known that exposure of the breast to ionizing radiation increases the relative risk of subsequent breast cancer, especially for younger women. However, the degree to which the patient's age contributes to the elevation of risk for subsequent development of breast cancer is not yet completely understood.
The purpose was to study the risk of breast cancer after irradiation of the female breast and, in particular, to analyze the duration of the effect and the risk for women older than 40 years at first exposure.
In this cohort study, data were obtained through population-based registers. The exposed group consisted of 1216 women (median age, 40 years) who, during the period spanning 1925 through 1954, received radiation therapy for benign breast disease. The reference group consisted of 1874 women (median age, 36 years) who had the same diagnosis during that time period but did not receive radiation therapy. The radiation doses were determined from the original medical records (mean dose, 5.8 Gy; range, 0.003-50.1 Gy). The follow-up lasted up to 60 years after first exposure. The incidence rate ratio was analyzed with Poisson regression models.
The total number of breast cancers in the exposed cohort was 198 versus 101 in the unexposed cohort. Overall, the radiation-associated incidence rate ratio was 3.58 (95% confidence interval = 2.77-4.63). The dose-response gradient was statistically significant (P < .001) but leveled off at higher doses. The incidence rate ratios decreased starting about 25 years after first exposure but were at increased levels throughout the entire follow-up period. The incidence rate ratio decreased with age at first exposure but was significantly increased (P < .001) even when the age at time of first exposure was greater than 40 years.
Total dose, age at first exposure, and time since first exposure were all determinants of the incidence rate ratio of breast cancer after exposure of the breast to ionizing radiation. A statistically significant increase in the incidence of breast cancer following radiation treatment of various benign breast diseases was observed even among women older than 40 years at the time of first treatment.
These findings need to be considered when weighing the relative benefits versus risks of generalized screening of younger women for breast cancer by mammography.
从20世纪20年代到50年代,瑞典将放射治疗用于良性乳腺疾病的治疗。现在已知乳房暴露于电离辐射会增加后续患乳腺癌的相对风险,尤其是对于年轻女性。然而,患者年龄对后续患乳腺癌风险升高的影响程度尚未完全明确。
本研究旨在探讨女性乳房接受放射治疗后患乳腺癌的风险,特别是分析这种影响的持续时间以及首次暴露时年龄超过40岁的女性的患病风险。
在这项队列研究中,数据通过基于人群的登记系统获取。暴露组由1216名女性(中位年龄40岁)组成,她们在1925年至1954年期间因良性乳腺疾病接受了放射治疗。对照组由1874名女性(中位年龄36岁)组成,她们在同一时期患有相同诊断但未接受放射治疗。放射剂量根据原始病历确定(平均剂量5.8 Gy;范围0.003 - 50.1 Gy)。随访持续至首次暴露后60年。采用泊松回归模型分析发病率比。
暴露队列中的乳腺癌总数为198例,未暴露队列中的乳腺癌总数为101例。总体而言,与放射相关的发病率比为3.58(95%置信区间 = 2.77 - 4.63)。剂量 - 反应梯度具有统计学意义(P <.001),但在较高剂量时趋于平稳。发病率比在首次暴露约25年后开始下降,但在整个随访期间一直处于升高水平。发病率比随首次暴露时的年龄增加而降低,但即使首次暴露时年龄大于40岁,发病率比仍显著升高(P <.001)。
总剂量、首次暴露时的年龄以及首次暴露后的时间均是乳房暴露于电离辐射后患乳腺癌发病率比的决定因素。即使在首次治疗时年龄超过40岁的女性中,也观察到各种良性乳腺疾病放射治疗后乳腺癌发病率有统计学意义的增加。
在权衡通过乳房X线摄影对年轻女性进行广泛乳腺癌筛查的相对益处与风险时,需要考虑这些发现。